Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Library Archives
Volume 20, 2016 Archive

Six issues from 2016 in one convenient archive.

  • Full-color, full-text PDF files of articles and formulations from the Journal.
  • Print or save articles for your research, marketing, and educational needs.
  • Log-in to your account for keyword or topical search and download.
  • Purchased items appear with download icon in contents and search results.

Only $30000


(Select Format)
Instant Online Access

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2016
Vol. 20 No. 1
Volume 20, Number 1
March/April 2016
Vol. 20 No. 2
Volume 20, Number 2
May/June 2016
Vol. 20 No. 3
Volume 20, Number 3
July/August 2016
Vol. 20 No. 4
Volume 20, Number 4
September/October 2016
Vol. 20 No. 5
Volume 20, Number 5
November/December 2016
Vol. 20 No. 6
Volume 20, Number 6

Volume 20, 2016 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Starting Year 20!
Allen Loyd V Jr
Jan/Feb 2016
Pg. 4

Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
Jan/Feb 2016
Pg. 6-10

Microbial Identification in Pharmaceutical Compounding
Hyde Tiffany
, Anstead James, Schade Lisa, Zellner James
Jan/Feb 2016
Pg. 13-18

Basic Principles of Lyophilization, Part 2
Akers Michael J
Jan/Feb 2016
Pg. 20-27

Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success
Pritchett Jon
, Mixon William, O'Connell Kevin
Jan/Feb 2016
Pg. 29-36

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Calculations
Stockton Shelly J
Jan/Feb 2016
Pg. 46

Aprepitant 80-mg Capsules
Allen Loyd V Jr
Jan/Feb 2016
Pg. 48

Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
Jan/Feb 2016
Pg. 49

Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
Jan/Feb 2016
Pg. 50

Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
Jan/Feb 2016
Pg. 51

Mupirocin Calcium 2% Cream
Allen Loyd V Jr
Jan/Feb 2016
Pg. 52

Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Allen Loyd V Jr
Jan/Feb 2016
Pg. 53

Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
Jan/Feb 2016
Pg. 54

Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 55

Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 56

Voriconazole 10-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 57

Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care
Guimarães Anna Luísa Aguiar
, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
Jan/Feb 2016
Pg. 58-62

Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Hergert Lisandro Y
, Ravetti Soledad, Mazzieri Maria R
Jan/Feb 2016
Pg. 63-70

A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob
, Weaver Sean, Caserta Francesco, Brown Marc B
Jan/Feb 2016
Pg. 71-80

Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
Jan/Feb 2016
Pg. 81-85

PostScription: The Home Field Advantage
Cabaleiro Joe
Jan/Feb 2016
Pg. 86-87

PreScription: Compounding: A Changing Paradigm
Allen Loyd V Jr
Mar/Apr 2016
Pg. 92

Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
McCrory Gary
Mar/Apr 2016
Pg. 95-96

Root Cause Analysis, Part 2: Sterile Compounding
Cabaleiro Joe
, Jackson Kathleen
Mar/Apr 2016
Pg. 99-104

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
Mar/Apr 2016
Pg. 107-113

Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives
Palmeira-de-Oliveira Rita
, Macedo Marina, Machado Rita M, Pacheco Ana Filipa, Palmeira-de-Oliveira Ana, Martinez-de-Oliveira José, Duarte Paulo
Mar/Apr 2016
Pg. 114-122

Basics of Compounding: Capsules
Allen Loyd V Jr
Mar/Apr 2016
Pg. 125-134

Formulation and Stability of Solutions
Akers Michael J
Mar/Apr 2016
Pg. 137-141

Calculations
Stockton Shelly J
Mar/Apr 2016
Pg. 142

Blue Goo Anti-Itch Gel
Allen Loyd V Jr
Mar/Apr 2016
Pg. 144

Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Allen Loyd V Jr
Mar/Apr 2016
Pg. 145

Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
Mar/Apr 2016
Pg. 146

Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Allen Loyd V Jr
Mar/Apr 2016
Pg. 147

Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe
, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Mar/Apr 2016
Pg. 148-154

Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon
, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016
Pg. 155-158

Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren
, Lewis Paul, Luu Yao, Brown Stacy
Mar/Apr 2016
Pg. 159-163

Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata Milap C
Mar/Apr 2016
Pg. 164-166

Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC
, Loures S, Lima LC, Ferreira AO, Brandão MA
Mar/Apr 2016
Pg. 167-174

PreScription: Patient Access to Pharmaceuticals
Allen Loyd V Jr
May/Jun 2016
Pg. 180

Current Perspectives on the Syringe Delivery System
Akers Michael J
May/Jun 2016
Pg. 182-186

Compounding in Nigeria
Alfred-Ugbenbo Deghinmotei
, Zdoryk Oleksandr A, Georgiyants Victoriya A, Schnatz Rick
May/Jun 2016
Pg. 189-192

IACP Names Voliva Executive Vice President
McCrory Gary
May/Jun 2016
Pg. 194

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M
, Collin Michael
May/Jun 2016
Pg. 197-201

Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

Basics of Compounding: Special Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 209-214

Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
May/Jun 2016
Pg. 217-222

Calculations
Stockton Shelly J
May/Jun 2016
Pg. 224

Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 226

Cefotetan Disodium Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 227

Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 2016
Pg. 228

Dexpanthenol 5% Nasal Spray
Allen Loyd V Jr
May/Jun 2016
Pg. 229

Indomethacin Gel
Allen Loyd V Jr
May/Jun 2016
Pg. 230

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
May/Jun 2016
Pg. 232

Pain-Away II Headache Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 233

Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 234

Zolpidem Tartrate 5-mg and 10-mg Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 235

Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky
, Shah Samit, Patel Jaymin, Thomas Michael C
May/Jun 2016
Pg. 236-238

Topical Metered-dosing Dispenser Performance Evaluation
Liu Qiang
, Kupiec Thomas C, Vu Nicole T
May/Jun 2016
Pg. 239-246

Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
May/Jun 2016
Pg. 247-249

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A
, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2016
Pg. 257-261

PostScription: Supporting Your Alma Mater: Whose World Will You Change?
Tigelaar Michele
May/Jun 2016
Pg. 262-263

PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing?
Allen Loyd V Jr
Jul/Aug 2016
Pg. 268

View Sample
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
Jul/Aug 2016
Pg. 271-274

Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha
, Harger Beau, Estrada Nick
Jul/Aug 2016
Pg. 277-280

Choosing a Vial Processing Line for Aseptic Compounding: Part 1
Noorian Shaun
, Vahedi Navid
Jul/Aug 2016
Pg. 283-292

IACP's 2016 Compounders on Capitol Hill Asks
Jul/Aug 2016
Pg. 294-296

Basics of Compounding: Compounding Films
Allen Loyd V Jr
Jul/Aug 2016
Pg. 298-305

Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
Jul/Aug 2016
Pg. 307-314

Calculations
Stockton Shelly J
Jul/Aug 2016
Pg. 316-317

Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2016
Pg. 318

Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 319

Mebendazole 100-mg Capsules
Allen Loyd V Jr
Jul/Aug 2016
Pg. 320

Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 321

Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
Jul/Aug 2016
Pg. 322

1,2-Octanediol 5% Topical Liquid
Allen Loyd V Jr
Jul/Aug 2016
Pg. 323

Phytonadione 1-mg/mL Oral Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 324

Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 325

Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 326

Tretinoin 10-mg Oral Capsules
Allen Loyd V Jr
Jul/Aug 2016
Pg. 327

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A
, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016
Pg. 328-332

Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José
, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
Jul/Aug 2016
Pg. 333-337

Stability of Ampicillin in Normal Saline and Buffered Normal Saline
Maher Moureddine
, Jensen Kara J, Lee David, Nix David E
Jul/Aug 2016
Pg. 338-342

Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Tomasello Cristina
, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
Jul/Aug 2016
Pg. 343-346

Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie
, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Jul/Aug 2016
Pg. 347-350

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals
Allen Loyd V Jr
Sep/Oct 2016
Pg. 356

Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
Sep/Oct 2016
Pg. 359-364

Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
Sep/Oct 2016
Pg. 367-374

More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard!
Voliva John
Sep/Oct 2016
Pg. 377-378

Quality Control Analytical Methods: Method Validation
Klang Mark G
, Williams LaVonn A
Sep/Oct 2016
Pg. 381-386

Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
Sep/Oct 2016
Pg. 389-396

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

Calculations
Stockton Shelly J
Sep/Oct 2016
Pg. 405

Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2016
Pg. 406

Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
Sep/Oct 2016
Pg. 407

Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 408

Levetiracetam 50-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2016
Pg. 409

Naproxen 5% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 410

Permethrin 1% Lotion
Allen Loyd V Jr
Sep/Oct 2016
Pg. 411

Progesterone 10% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 412

Sodium Phosphate Oral Solution
Allen Loyd V Jr
Sep/Oct 2016
Pg. 413

Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
Sep/Oct 2016
Pg. 414

Tromethamine Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 415

Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Huvelle Sophie
, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Sep/Oct 2016
Pg. 416-420

Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V
, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
Sep/Oct 2016
Pg. 421-425

Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Polonini Hudson C
, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
Sep/Oct 2016
Pg. 426-434

Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light
Anderson Collin R
, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
Sep/Oct 2016
Pg. 435-437

A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Tannous Elias
, Tal Yana, Amarny Kamal
Sep/Oct 2016
Pg. 438-439

PreScription: Two Decades of IJPC
Allen Loyd V Jr
Nov/Dec 2016
Pg. 444

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454

U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Nov/Dec 2016
Pg. 457-458

Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H
, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Nov/Dec 2016
Pg. 461-467

Why Become Pharmacy Compounding Accreditation Board Accredited?
Dillon L Rad
Nov/Dec 2016
Pg. 469-474

The "Lists": What Do They Mean?
Voliva John
Nov/Dec 2016
Pg. 477-479

Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
Nov/Dec 2016
Pg. 481-484

Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Calculations
Stockton Shelly J
Nov/Dec 2016
Pg. 502

Alendronate 70-mg/75-mL Drinkable Formulation
Allen Loyd V Jr
Nov/Dec 2016
Pg. 504

Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 505

Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
Nov/Dec 2016
Pg. 506

Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
Nov/Dec 2016
Pg. 507

Erlotinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 508

Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2016
Pg. 509

Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 510

Lapatinib Ditosylate 50-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 511

Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 512

Menthol, Chloral Hydrate, and Camphor Analgesic Ointment
Allen Loyd V Jr
Nov/Dec 2016
Pg. 513

Stability of Fentanyl Citrate in Polyolefin Bags
Donnelly Ronald F
Nov/Dec 2016
Pg. 514-516

Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph
, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2016
Pg. 517-520

Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli
, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Nov/Dec 2016
Pg. 521-525

PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution
Rost Erika
Nov/Dec 2016
Pg. 526-527

Return to Top